| Product Code: ETC9681091 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market - Industry Life Cycle |
3.4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market - Porter's Five Forces |
3.5 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.7 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Population Type, 2021 & 2031F |
3.8 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Thailand |
4.2.2 Growing adoption of chemotherapy as a treatment option |
4.2.3 Rising awareness about the importance of managing chemotherapy-induced nausea and vomiting |
4.3 Market Restraints |
4.3.1 High cost associated with chemotherapy-induced nausea and vomiting drugs |
4.3.2 Side effects and lack of efficacy of current treatment options |
5 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Trends |
6 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By Types |
6.1 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Acute Emesis, 2021- 2031F |
6.1.4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Delayed Emesis, 2021- 2031F |
6.1.5 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Anticipatory Emesis and Refractory Emesis, 2021- 2031F |
6.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By Therapy |
6.2.1 Overview and Analysis |
6.2.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Nk-1 Receptor Antagonist, 2021- 2031F |
6.2.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Serotonin Receptor Antagonist, 2021- 2031F |
6.2.4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By Population Type |
6.3.1 Overview and Analysis |
6.3.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Childrens, 2021- 2031F |
6.3.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Adults, 2021- 2031F |
6.4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Generics, 2021- 2031F |
6.5 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6.4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.6.5 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.7 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.7.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.7.4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Import-Export Trade Statistics |
7.1 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Export to Major Countries |
7.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Imports from Major Countries |
8 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Key Performance Indicators |
8.1 Number of patients undergoing chemotherapy in Thailand |
8.2 Adoption rate of new and improved chemotherapy-induced nausea and vomiting drugs |
8.3 Rate of compliance with prescribed medications among chemotherapy patients |
9 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market - Opportunity Assessment |
9.1 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.3 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Population Type, 2021 & 2031F |
9.4 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market - Competitive Landscape |
10.1 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Revenue Share, By Companies, 2024 |
10.2 Thailand Chemotherapy Induced Nausea and Vomiting Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here